Erythrocytes‐mediated metabolic activation of cyclophosphamide in yeast mutagenicity test
- 1 January 1985
- journal article
- research article
- Published by Wiley in Teratogenesis, Carcinogenesis, and Mutagenesis
- Vol. 5 (4) , 223-230
- https://doi.org/10.1002/tcm.1770050403
Abstract
The degree of conversion of cyclophosphamide (CP) into mutagenic intermediates was studied using mouse erythrocytes as the metabolic activation system. The amount of mutagenic intermediates produced was measured indirectly in terms of induced frequencies of mitotic recombination, mitotic gene conversion, and reverse mutation in the diploid D7 strain of Saccharomyces cerevisiae. In the absence of S9 microsomal fraction or erythrocytes, CP did not induce any genetic response. In the presence of erythrocytes, on the other hand, CP clearly induced increases in the three genetic endpoints. The responses, however, were lower than those observed with the S9 activation system. The activating principle seems to be the oxyhemoglobin. In fact, neither p‐nitroanisole O‐demethylase activity nor genotoxic responses performed with red‐blood cells from uninduced and PB‐induced mice indicate that (possible) water‐soluble forms of cytochrome P‐450 were responsible for the activation of CP by erythrocytes.Keywords
This publication has 19 references indexed in Scilit:
- Mutagenic activities of cyclophosphamide (NSC-26271) and its main metabolites in Salmonella typhimurium, human peripheral lymphocytes and Chinese hamster ovary cellsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1984
- An attempt to activate styrene by erythrocytes in bacterial mutagenicity assaysMutation Research/Environmental Mutagenesis and Related Subjects, 1984
- Stability of microsomal mono-oxygenase during incubations for the liver microsomal assay with S9 fractions of mouse liver under various inductionsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1983
- Styrene oxidation to styrene oxide in human erythrocytes is catalyzed by oxyhemoglobinCellular and Molecular Life Sciences, 1983
- Mutagenic, teratogenic and pharmacokinetic properties of cyclophosphamide and some of its deuterated derivativesMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1982
- Toxicity, interstrand cross-links and DNA fragmentation induced by ‘activated’ cyclophosphamide in yeast: Comparative studies on 4-hydroperoxy-cyclophosphamide, its monofunctional analogon, acrolein, phosphoramide mustard, and nor-nitrogen mustardChemico-Biological Interactions, 1982
- Sister-chromatid exchanges induced in vitro by cyclophosphamide without exogenous metabolic activation in lymphocytes from three mammalian speciesToxicology Letters, 1981
- Mutagenic activity of major mammalian metabolites of cyclophosphamide toward several genes ofEscherichia coliJournal of Toxicology and Environmental Health, 1977
- A yeast strain for simultaneous detection of induced mitotic crossing over, mitotic gene conversion and reverse mutationMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1975
- Aniline hydroxylation in the human placenta—Mechanistic aspectsBiochemical Pharmacology, 1972